The introduction of new antifungal agents together with the emergence of new fungal species with unknown susceptibility requires surveillance for the detection of isolates with decreased susceptibility to antifungal agents, especially in critical care setting, in order to optimize the antifungal treatment. The aim of this study was to determine whether there are any differences in the antifungal agent resistance rates between ICU and non ICU adult patients in the age of new agents.
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
- ECCMID 22nd (2012)